These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 10654899)
1. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. de la Taille A; Hayek O; Benson MC; Bagiella E; Olsson CA; Fatal M; Katz AE Urology; 2000 Jan; 55(1):79-84. PubMed ID: 10654899 [TBL] [Abstract][Full Text] [Related]
2. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882 [TBL] [Abstract][Full Text] [Related]
3. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy. Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004 [TBL] [Abstract][Full Text] [Related]
4. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068 [TBL] [Abstract][Full Text] [Related]
5. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer. Kvorning Ternov K; Krag Jakobsen A; Bratt O; Ahlgren G Scand J Urol; 2015 Apr; 49(2):115-9. PubMed ID: 25428754 [TBL] [Abstract][Full Text] [Related]
6. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation. Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312 [TBL] [Abstract][Full Text] [Related]
7. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of prostate specific antigen nadir after salvage cryotherapy. Greene GF; Pisters LL; Scott SM; Von Eschenbach AC J Urol; 1998 Jul; 160(1):86-90. PubMed ID: 9628611 [TBL] [Abstract][Full Text] [Related]
9. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS Perm J; 2019; 23():. PubMed ID: 31050644 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and complications of salvage cryotherapy of the prostate. Pisters LL; von Eschenbach AC; Scott SM; Swanson DA; Dinney CP; Pettaway CA; Babaian RJ J Urol; 1997 Mar; 157(3):921-5. PubMed ID: 9072600 [TBL] [Abstract][Full Text] [Related]
11. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. Pisters LL; Perrotte P; Scott SM; Greene GF; von Eschenbach AC J Clin Oncol; 1999 Aug; 17(8):2514-20. PubMed ID: 10561317 [TBL] [Abstract][Full Text] [Related]
12. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783 [TBL] [Abstract][Full Text] [Related]
13. Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy. Chang X; Liu T; Zhang F; Zhao X; Ji C; Yang R; Gan W; Zhang G; Li X; Guo H Int Urol Nephrol; 2015 Feb; 47(2):301-5. PubMed ID: 25510358 [TBL] [Abstract][Full Text] [Related]
15. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778 [TBL] [Abstract][Full Text] [Related]
16. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984 [TBL] [Abstract][Full Text] [Related]
17. Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience. Philippou P; Yap T; Chinegwundoh F Urol Int; 2012; 88(2):137-44. PubMed ID: 22285952 [TBL] [Abstract][Full Text] [Related]
18. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Kupelian PA; Katcher J; Levin HS; Klein EA Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811 [TBL] [Abstract][Full Text] [Related]
19. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120 [TBL] [Abstract][Full Text] [Related]
20. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]